Skip to contentC
Chemed Corp
C
CHEChemed Corp Q3 2013 · 10-Q
Revenue$340.89M$340.89M−3.8% vs Q3 2012 Net Income$17.43M$17.43M−16.4% vs Q3 2012 EPS Diluted$0.94$0.94−12.1% vs Q3 2012 Operating Income$29,210,000−18.8% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$44,505,000+203.4% Margins · derivedOperating margin8.6%−1.6 pt vs Q3 2012
Net margin5.1%−0.8 pt vs Q3 2012
ended Sep 30, 2013 · filed Nov 1, 2013 · 32 d after period end